April 3, 2015

Three Pharmaceutics Graduate Students Selected for Prestigious ITHS TL1 Scholar Award

image1

Congratulations go to Brian Chapron, Cate Lockhart and Savannah Kerr  and  who were selected as Institute of Translational Health Sciences (ITHS) TL1 scholars starting Summer 2016. They will be participating in curriculum and interdisciplinary clinical and translational training in the program.

Cate will be conducting a pilot study of intravitreal gene therapy in mice that lack the cyp4v3 gene, a genetic cause of Bietti’s crystalline dystrophy. She will be identifying therapeutic vector candidates and evaluate wither these work to either delay or reverse blindness in these mice.

Brian will be doing studies with tacrolimus, a drug used to prevent organ rejection after transplant surgery. He will be doing experiments to understand how kidneys in patients with different CYP3A5 genotypes handle the drug and why some patients are at increased risk for kidney toxicity from tacrolimus treatment.

Lastly, Savannah will be using physiologically-based pharmacokinetic modeling to predict how the concentrations of drug changes following Roux-en-Y gastric bypass surgery. The ITHS is dedicated to speeding science to the clinic for the benefit of patients and communities throughout Washington, Wyoming, Alaska, Montana, and Idaho.

Link to Pharmaceutics archived news